Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
0985B | Carbinoxamine, Blood |
1040B | Cetirizine, Blood |
1040SP | Cetirizine, Serum/Plasma |
1040U | Cetirizine, Urine |
1190B | Chlorpheniramine, Blood |
1190SP | Chlorpheniramine, Serum/Plasma |
1190U | Chlorpheniramine, Urine |
1270B | Clonazepam and Metabolite, Blood |
1270FL | Clonazepam and Metabolite, Fluid |
1270SP | Clonazepam and Metabolite, Serum/Plasma |
1270TI | Clonazepam and Metabolite, Tissue |
1270U | Clonazepam and Metabolite, Urine |
1280U | Clorazepate as Metabolite, Urine |
1425B | Cyproheptadine, Blood |
1425SP | Cyproheptadine, Serum/Plasma |
1425U | Cyproheptadine, Urine |
9139B | Clonazepam and Metabolite Screen, Blood |
9139FL | Clonazepam and Metabolite Screen, Fluid |
9139SP | Clonazepam and Metabolite Screen, Serum/Plasma |
9139U | Clonazepam and Metabolite Screen, Urine |
9145UC | Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |